Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

MLA

Botta-Orfila, Teresa, et al. “Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.” Cerebellum, vol. 15, no. 5, Oct. 2016, pp. 599–610. EBSCOhost, https://doi.org/10.1007/s12311-016-0800-2.

APA

Botta-Orfila, T., Tartaglia, G., & Michalon, A. (2016). Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development. Cerebellum, 15(5), 599–610. https://doi.org/10.1007/s12311-016-0800-2

Chicago

Botta-Orfila, Teresa, Gian Tartaglia, and Aubin Michalon. 2016. “Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.” Cerebellum 15 (5): 599–610. doi:10.1007/s12311-016-0800-2.